MYO - Myomo EPS beats by $0.18 beats on revenue
Myomo (MYO): Q4 Non-GAAP EPS of -$0.37 beats by $0.18; GAAP EPS of -$0.36 beats by $0.13.Revenue of $3.79M (+149.3% Y/Y) beats by $0.44M.101 units were delivered to patients including 97 recognized as revenue, a 126% increase.Backlog, which represents insurance authorizations received but not yet converted to revenue, was 131 units as of Dec. 31, 2020."With more than $7M in proceeds received from the exercise of warrants so far during the 1Q21, we believe we have sufficient cash to fund operations well into 2022," CFO David Henry commented.Press Release
For further details see:
Myomo EPS beats by $0.18, beats on revenue